Variant Bio, Inc.

Biotechnology company using genomic and population research to discover therapeutic targets and develop medicines for diseases. Its reported pipeline includes preclinical programs for retinal disease, fibrosis, and inflammation, alongside genetic studies of metabolic conditions, gout, and kidney disease.